Evidence map›Paper›PMID 41403421›Full record

ArticleERJ open research2025

Acute coronary syndrome after an infective exacerbation of COPD: a prospective cohort study of acute lower respiratory tract disease in hospitalised adults.

Caitlin Morgan, Robert Challen, Elizabeth Begier, Jo Southern, George Nava, George Qian, Serena McGuinness, Jade King, Nick Maskell, Maria Lahuerta and 6 more

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Caitlin MorganAcademic Respiratory Unit, Bristol Medical School, University of Bristol and Bristol NIHR Biomedical Research Centre, Bristol, UK.ORCID https://orcid.org/0000-0003-3923-1773
Robert ChallenEngineering and Mathematics, University of Bristol, Bristol, UK.
Elizabeth BegierPfizer Vaccines, Collegeville, PA, USA.
Jo SouthernPfizer Vaccines, Collegeville, PA, USA.
George NavaPfizer Vaccines, Collegeville, PA, USA.
George QianEngineering and Mathematics, University of Bristol, Bristol, UK.
Serena McGuinnessBristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK.
Jade KingClinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Trust, Bristol, UK.
Nick MaskellAcademic Respiratory Unit, Bristol Medical School, University of Bristol and Bristol NIHR Biomedical Research Centre, Bristol, UK.
Maria LahuertaPfizer Vaccines, Collegeville, PA, USA.
Jennifer OliverBristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK.
Bradford D GessnerPfizer Vaccines, Collegeville, PA, USA.
Adam FinnBristol Vaccine Centre, Population Health Sciences, University of Bristol, Bristol, UK.
Leon DanonEngineering and Mathematics, University of Bristol, Bristol, UK.
Catherine HyamsAcademic Respiratory Unit, Bristol Medical School, University of Bristol and Bristol NIHR Biomedical Research Centre, Bristol, UK.ORCID https://orcid.org/0000-0003-3923-1773
James W DoddAcademic Respiratory Unit, Bristol Medical School, University of Bristol and Bristol NIHR Biomedical Research Centre, Bristol, UK.ORCID https://orcid.org/0000-0003-4805-5759

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Comorbid cardiovascular disease has been reported extensively in community COPD populations, but to a lesser degree in acute hospital settings. Shared risk factors and acute infection both increase acute coronary syndrome (ACS) risk. Our objective is to assess a cohort of adults hospitalised for an acute lower respiratory tract infection (aLRTI) to determine whether COPD status is an independent risk factor for ACS. Methods: A prospective observational cohort study of adults aged ≥40 years (n=8496) with community-acquired aLRTI (Bristol, UK) was conducted between 27 July 2020 and 28 November 2022. Cases included physician diagnosis of COPD; controls were aLRTI without COPD. Outcomes included physician-diagnosed ACS occurring within 30 days of admission. Logistic regression models were adjusted for shared cardiovascular risk factors and aLRTI severity. Results: 30-day ACS events in patients hospitalised with aLRTI with COPD were 7.59% (190 out of 2502), Conclusions: In this large, real-world cohort of hospitalised adults with aLRTI, 30-day ACS event rates were high at ∼7-13%. A diagnosis of COPD even in the absence of pneumonia increases ACS risk

Identifiers

PMID41403421
PMCPMC12704152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.